COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1LIFE HEALTHCARE INC | NOTE 3.000% 6/1 | 68269GAB3 | 39,377 | 40,599,000 | PRN | | DFND | 1 | 40,599,000 | 0 | 0 |
ACCOLADE INC | NOTE 0.500% 4/0 | 00437EAB8 | 79,078 | 105,000,000 | PRN | | DFND | 1 | 105,000,000 | 0 | 0 |
ACUTUS MED INC | COM | 005111109 | 2,333 | 2,651,667 | SH | | DFND | 1 | 2,651,667 | 0 | 0 |
ADAPTHEALTH CORP | COMMON STOCK | 00653Q102 | 154,438 | 8,223,536 | SH | | DFND | 1 | 8,223,536 | 0 | 0 |
ADC THERAPEUTICS SA | SHS | H0036K147 | 11,521 | 2,390,297 | SH | | DFND | 1 | 2,390,297 | 0 | 0 |
AERIE PHARMACEUTICALS INC | NOTE 1.500%10/0 | 00771VAB4 | 170,826 | 174,372,000 | PRN | | DFND | 1 | 174,372,000 | 0 | 0 |
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 73,456 | 4,855,005 | SH | | DFND | 1 | 4,855,005 | 0 | 0 |
ALECTOR INC | COM | 014442107 | 9,982 | 1,055,192 | SH | | DFND | 1 | 1,055,192 | 0 | 0 |
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 22,137 | 2,532,792 | SH | | DFND | 1 | 2,532,792 | 0 | 0 |
ALPHATEC HLDGS INC | NOTE 0.750% 8/0 | 02081GAB8 | 81,430 | 100,000,000 | PRN | | DFND | 1 | 100,000,000 | 0 | 0 |
AMEDISYS INC | COM | 023436108 | 34,822 | 359,765 | SH | | DFND | 1 | 359,765 | 0 | 0 |
AN2 THERAPEUTICS INC | COM | 037326105 | 12,453 | 716,538 | SH | | DFND | 1 | 716,538 | 0 | 0 |
ANAPTYSBIO INC | COM | 032724106 | 37,413 | 1,466,600 | SH | | DFND | 1 | 1,466,600 | 0 | 0 |
ANNEXON INC | COM | 03589W102 | 3,609 | 583,913 | SH | | DFND | 1 | 583,913 | 0 | 0 |
APELLIS PHARMACEUTICALS INC | NOTE 3.500% 9/1 | 03753UAB2 | 99,115 | 51,885,000 | PRN | | DFND | 1 | 51,885,000 | 0 | 0 |
APOLLO ENDOSURGERY INC | COM | 03767D108 | 9,643 | 1,750,000 | SH | | DFND | 1 | 1,750,000 | 0 | 0 |
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 32,535 | 3,081,000 | SH | | DFND | 1 | 3,081,000 | 0 | 0 |
BIOGEN INC | COM | 09062X103 | 88,110 | 330,000 | SH | | DFND | 1 | 330,000 | 0 | 0 |
BROOKDALE SR LIVING INC | COM | 112463104 | 37,117 | 8,692,561 | SH | | DFND | 1 | 8,692,561 | 0 | 0 |
BUTTERFLY NETWORK INC | *W EXP 02/12/202 | 124155110 | 616 | 733,333 | SH | | DFND | 1 | 733,333 | 0 | 0 |
CABALETTA BIO INC | COM | 12674W109 | 302 | 464,252 | SH | | DFND | 1 | 464,252 | 0 | 0 |
CAREMAX INC | COM CL A | 14171W103 | 112,455 | 15,861,090 | SH | | DFND | 1 | 15,861,090 | 0 | 0 |
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 1,263 | 672,000 | SH | | DFND | 1 | 672,000 | 0 | 0 |
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 62,816 | 4,896,000 | SH | | DFND | 1 | 4,896,000 | 0 | 0 |
CENTENE CORP DEL | COM | 15135B101 | 36,104 | 464,000 | SH | | DFND | 1 | 464,000 | 0 | 0 |
COGENT BIOSCIENCES INC | COM | 19240Q201 | 44,258 | 2,966,345 | SH | | DFND | 1 | 2,966,345 | 0 | 0 |
CYTOKINETICS INC | COM NEW | 23282W605 | 39,395 | 813,112 | SH | | DFND | 1 | 813,112 | 0 | 0 |
DA32 LIFE SCNCE TEC ACQSTN C | CLASS A COM | 23312M106 | 15,568 | 1,600,000 | SH | | DFND | 1 | 1,600,000 | 0 | 0 |
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 20,671 | 1,032,000 | SH | | DFND | 1 | 1,032,000 | 0 | 0 |
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 46,093 | 2,491,490 | SH | | DFND | 1 | 2,491,490 | 0 | 0 |
DELCATH SYS INC | COM NEW | 24661P807 | 1,555 | 486,068 | SH | | DFND | 1 | 486,068 | 0 | 0 |
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 38,702 | 3,933,137 | SH | | DFND | 1 | 3,933,137 | 0 | 0 |
ENHABIT INC | COM | 29332G102 | 20,418 | 1,454,279 | SH | | DFND | 1 | 1,454,279 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 13 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 0 | 1 | SH | | DFND | 1 | 1 | 0 | 0 |
EUCRATES BIOMEDICAL ACQUISIT | SHS | G3141W106 | 10,020 | 999,999 | SH | | DFND | 1 | 999,999 | 0 | 0 |
EVOLUS INC | COM | 30052C107 | 43,390 | 5,390,103 | SH | | DFND | 1 | 5,390,103 | 0 | 0 |
FOGHORN THERAPEUTICS INC | COM | 344174107 | 6,671 | 777,525 | SH | | DFND | 1 | 777,525 | 0 | 0 |
GILEAD SCIENCES INC | COM | 375558103 | 94,851 | 1,537,539 | SH | | DFND | 1 | 1,537,539 | 0 | 0 |
GLAUKOS CORP | NOTE 2.750% 6/1 | 377322AB8 | 355,849 | 271,752,000 | PRN | | DFND | 1 | 271,752,000 | 0 | 0 |
GLAUKOS CORP | COM | 377322102 | 0 | 0 | SH | | DFND | 1 | 0 | 0 | 0 |
GRAYBUG VISION INC | COMMON | 38942Q103 | 4,967 | 5,281,713 | SH | | DFND | 1 | 5,281,713 | 0 | 0 |
GUARDANT HEALTH INC | NOTE 11/1 | 40131MAB5 | 65,033 | 89,036,000 | PRN | | DFND | 1 | 89,036,000 | 0 | 0 |
HEALTH CATALYST INC | NOTE 2.500% 4/1 | 42225TAB3 | 25,533 | 30,000,000 | PRN | | DFND | 1 | 30,000,000 | 0 | 0 |
HILLEVAX INC | COM | 43157M102 | 45,344 | 2,653,231 | SH | | DFND | 1 | 2,653,231 | 0 | 0 |
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 26,015 | 1,743,628 | SH | | DFND | 1 | 1,743,628 | 0 | 0 |
IGNYTE ACQUISITION CORP | *W EXP 01/05/202 | 45175H114 | 45 | 362,500 | SH | | DFND | 1 | 362,500 | 0 | 0 |
IGNYTE ACQUISITION CORP | COM | 45175H106 | 7,236 | 725,000 | SH | | DFND | 1 | 725,000 | 0 | 0 |
IMMUNOGEN INC | COM | 45253H101 | 65,678 | 13,740,205 | SH | | DFND | 1 | 13,740,205 | 0 | 0 |
INOZYME PHARMA INC | COM | 45790W108 | 5,602 | 2,090,436 | SH | | DFND | 1 | 2,090,436 | 0 | 0 |
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 73,212 | 75,000,000 | PRN | | DFND | 1 | 75,000,000 | 0 | 0 |
INSMED INC | COM PAR $.01 | 457669307 | 20,689 | 960,484 | SH | | DFND | 1 | 960,484 | 0 | 0 |
INTERCEPT PHARMACEUTICALS IN | NOTE 3.500% 2/1 | 45845PAC2 | 81,098 | 78,500,000 | PRN | | DFND | 1 | 78,500,000 | 0 | 0 |
INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 45845PAA6 | 56,098 | 57,791,000 | PRN | | DFND | 1 | 57,791,000 | 0 | 0 |
INVITAE CORP | NOTE 2.000% 9/0 | 46185LAB9 | 162,218 | 206,873,000 | PRN | | DFND | 1 | 206,873,000 | 0 | 0 |
IONIS PHARMACEUTICALS INC | NOTE 4/0 | 462222AD2 | 128,518 | 127,800,000 | PRN | | DFND | 1 | 127,800,000 | 0 | 0 |
IVERIC BIO INC | COM | 46583P102 | 76,139 | 4,244,098 | SH | | DFND | 1 | 4,244,098 | 0 | 0 |
IVERIC BIO INC | COM | 46583P102 | 8,073 | 450,000 | SH | Call | DFND | 1 | 450,000 | 0 | 0 |
IVERIC BIO INC | COM | 46583P102 | 9,867 | 550,000 | SH | Call | DFND | 1 | 550,000 | 0 | 0 |
KINNATE BIOPHARMA INC | COM | 49705R105 | 2,988 | 250,000 | SH | | DFND | 1 | 250,000 | 0 | 0 |
KRYSTAL BIOTECH INC | COM | 501147102 | 12,198 | 175,000 | SH | | DFND | 1 | 175,000 | 0 | 0 |
KURA ONCOLOGY INC | COM | 50127T109 | 30,313 | 2,219,128 | SH | | DFND | 1 | 2,219,128 | 0 | 0 |
LARIMAR THERAPEUTICS INC | COM | 517125100 | 54,212 | 16,941,357 | SH | | DFND | 1 | 16,941,357 | 0 | 0 |
MEDAVAIL HOLDINGS INC | COM | 58406B103 | 649 | 836,626 | SH | | DFND | 1 | 836,626 | 0 | 0 |
MEDTECH ACQUISITION CORP | UNIT 12/18/2025 | 58507N204 | 0 | 1 | SH | | DFND | 1 | 1 | 0 | 0 |
MEDTECH ACQUISITION CORP | COM CL A | 58507N105 | 9,930 | 999,999 | SH | | DFND | 1 | 999,999 | 0 | 0 |
MEDTECH ACQUISITION CORP | *W EXP 12/22/202 | 58507N113 | 20 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
MERUS N V | COM | N5749R100 | 50,507 | 2,521,553 | SH | | DFND | 1 | 2,521,553 | 0 | 0 |
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 42,699 | 2,032,335 | SH | | DFND | 1 | 2,032,335 | 0 | 0 |
MOLINA HEALTHCARE INC | COM | 60855R100 | 24,738 | 75,000 | SH | | DFND | 1 | 75,000 | 0 | 0 |
NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 48,669 | 57,604,000 | PRN | | DFND | 1 | 57,604,000 | 0 | 0 |
NATERA INC | NOTE 2.250% 5/0 | 632307AB0 | 51,398 | 37,638,000 | PRN | | DFND | 1 | 37,638,000 | 0 | 0 |
NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 5,571 | 6,500,000 | PRN | | DFND | 1 | 6,500,000 | 0 | 0 |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 160,665 | 1,512,714 | SH | | DFND | 1 | 1,512,714 | 0 | 0 |
NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 39,609 | 42,000,000 | PRN | | DFND | 1 | 42,000,000 | 0 | 0 |
NOVAVAX INC | NOTE 3.750% 2/0 | 670002AB0 | 24,388 | 25,000,000 | PRN | | DFND | 1 | 25,000,000 | 0 | 0 |
NUVALENT INC | COM | 670703107 | 375,990 | 19,341,024 | SH | | DFND | 1 | 19,341,024 | 0 | 0 |
NUVASIVE INC | NOTE 1.000% 6/0 | 670704AL9 | 93,716 | 96,966,000 | PRN | | DFND | 1 | 96,966,000 | 0 | 0 |
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 33 | 166,666 | SH | | DFND | 1 | 166,666 | 0 | 0 |
NUVATION BIO INC | COM CL A | 67080N101 | 550 | 245,360 | SH | | DFND | 1 | 245,360 | 0 | 0 |
NYXOAH S A | SHS | B6S7WD106 | 2,868 | 455,262 | SH | | DFND | 1 | 455,262 | 0 | 0 |
OAK STR HEALTH INC | NOTE 3/1 | 67181AAB3 | 52,497 | 68,000,000 | SH | | DFND | 1 | 68,000,000 | 0 | 0 |
ONCORUS INC | COM | 68236R103 | 2,677 | 3,148,977 | SH | | DFND | 1 | 3,148,977 | 0 | 0 |
ORCHARD THERAPEUTICS PLC | SPON ADS | 68570P101 | 3,475 | 6,949,416 | SH | | DFND | 1 | 6,949,416 | 0 | 0 |
ORION ACQUISITION CORP | *W EXP 02/19/202 | 68626A116 | 7 | 125,000 | SH | | DFND | 1 | 125,000 | 0 | 0 |
ORION ACQUISITION CORP | COM CL A | 68626A108 | 4,923 | 500,000 | SH | | DFND | 1 | 500,000 | 0 | 0 |
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 11,732 | 2,021,000 | SH | | DFND | 1 | 2,021,000 | 0 | 0 |
PACIRA BIOSCIENCES INC | COM | 695127100 | 15,531 | 292,000 | SH | | DFND | 1 | 292,000 | 0 | 0 |
PACIRA BIOSCIENCES INC | NOTE 0.750% 8/0 | 695127AF7 | 80,771 | 81,600,000 | PRN | | DFND | 1 | 81,600,000 | 0 | 0 |
PEPGEN INC | COM | 713317105 | 6,767 | 745,293 | SH | | DFND | 1 | 745,293 | 0 | 0 |
PHARVARIS N V | COM | N69605108 | 8,472 | 1,104,552 | SH | | DFND | 1 | 1,104,552 | 0 | 0 |
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 26,757 | 2,414,897 | SH | | DFND | 1 | 2,414,897 | 0 | 0 |
PHREESIA INC | COM | 71944F106 | 34,602 | 1,358,000 | SH | | DFND | 1 | 1,358,000 | 0 | 0 |
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 7,730 | 1,000,000 | SH | | DFND | 1 | 1,000,000 | 0 | 0 |
PROFOUND MED CORP | COM NEW | 74319B502 | 2,959 | 732,543 | SH | | DFND | 1 | 732,543 | 0 | 0 |
PTC THERAPEUTICS INC | NOTE 1.500% 9/1 | 69366JAD3 | 37,558 | 32,000,000 | PRN | | DFND | 1 | 32,000,000 | 0 | 0 |
PULMONX CORP | COM | 745848101 | 61,990 | 3,720,901 | SH | | DFND | 1 | 3,720,901 | 0 | 0 |
QUANTUM SI INC | COM CL A | 74765K105 | 3,850 | 1,400,000 | SH | | DFND | 1 | 1,400,000 | 0 | 0 |
QUANTUM SI INC | *W EXP 06/10/202 | 74765K113 | 177 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
REVOLUTION HEALTHCAR AQ CORP | CLASS A COM | 76155Y108 | 9,820 | 1,000,000 | SH | | DFND | 1 | 1,000,000 | 0 | 0 |
REVOLUTION HEALTHCAR AQ CORP | *W EXP 12/31/202 | 76155Y116 | 9 | 200,000 | SH | | DFND | 1 | 200,000 | 0 | 0 |
REVOLUTION MEDICINES INC | COM | 76155X100 | 57,022 | 2,891,587 | SH | | DFND | 1 | 2,891,587 | 0 | 0 |
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 13,885 | 870,000 | SH | | DFND | 1 | 870,000 | 0 | 0 |
ROIVANT SCIENCES LTD | *W EXP 09/30/202 | G76279119 | 390 | 1,000,000 | SH | | DFND | 1 | 1,000,000 | 0 | 0 |
SAREPTA THERAPEUTICS INC | DBCV 1.500%11/1 | 803607AB6 | 148,264 | 88,657,000 | PRN | | DFND | 1 | 88,657,000 | 0 | 0 |
SARISSA CAPITAL ACQUISITN CO | UNIT 10/23/2027 | G7823W128 | 0 | 1 | SH | | DFND | 1 | 1 | 0 | 0 |
SARISSA CAPITAL ACQUISITN CO | CL A | G7823W102 | 10,000 | 999,999 | SH | | DFND | 1 | 999,999 | 0 | 0 |
SARISSA CAPITAL ACQUISITN CO | *W EXP 10/23/202 | G7823W110 | 7 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 14,894 | 16,973,488 | SH | | DFND | 1 | 16,973,488 | 0 | 0 |
SENIOR CONNECT ACQUISITN COR | *W EXP 12/31/202 | 81723H116 | 10 | 500,000 | SH | | DFND | 1 | 500,000 | 0 | 0 |
SENIOR CONNECT ACQUISITN COR | COM CL A | 81723H108 | 9,945 | 1,000,000 | SH | | DFND | 1 | 1,000,000 | 0 | 0 |
SILK RD MED INC | COM | 82710M100 | 114,092 | 2,535,369 | SH | | DFND | 1 | 2,535,369 | 0 | 0 |
SINGULAR GENOMICS SYSTEMS IN | COM | 82933R100 | 17,695 | 7,078,019 | SH | | DFND | 1 | 7,078,019 | 0 | 0 |
SOMALOGIC INC | *W EXP 08/31/202 | 83444K113 | 53 | 120,000 | SH | | DFND | 1 | 120,000 | 0 | 0 |
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 23,309 | 816,994 | SH | | DFND | 1 | 816,994 | 0 | 0 |
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 31 | 166,666 | SH | | DFND | 1 | 166,666 | 0 | 0 |
TABULA RASA HEALTHCARE INC | NOTE 1.750% 2/1 | 873379AA9 | 115,533 | 144,516,000 | PRN | | DFND | 1 | 144,516,000 | 0 | 0 |
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 22,671 | 1,324,214 | SH | | DFND | 1 | 1,324,214 | 0 | 0 |
LIVONGO HEALTH INC | NOTE 0.875% 6/0 | 539183AA1 | 41,977 | 50,000,000 | PRN | | DFND | 1 | 50,000,000 | 0 | 0 |
TERNS PHARMACEUTICALS INC | COM | 880881107 | 10,955 | 1,860,000 | SH | | DFND | 1 | 1,860,000 | 0 | 0 |
TG THERAPEUTICS INC | COM | 88322Q108 | 15,851 | 2,677,500 | SH | | DFND | 1 | 2,677,500 | 0 | 0 |
THE ONCOLOGY INSTITUTE INC | *W EXP 11/15/202 | 68236X118 | 691 | 1,250,000 | SH | | DFND | 1 | 1,250,000 | 0 | 0 |
THE ONCOLOGY INSTITUTE INC | COM | 68236X100 | 15,557 | 3,360,052 | SH | | DFND | 1 | 3,360,052 | 0 | 0 |
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 7 | 250,000 | SH | | DFND | 1 | 250,000 | 0 | 0 |
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 7,500 | 750,000 | SH | | DFND | 1 | 750,000 | 0 | 0 |
VERICEL CORP | COM | 92346J108 | 11,251 | 484,947 | SH | | DFND | 1 | 484,947 | 0 | 0 |
VERVE THERAPEUTICS INC | COM | 92539P101 | 25,763 | 750,000 | SH | | DFND | 1 | 750,000 | 0 | 0 |
VIATRIS INC | COM | 92556V106 | 90,940 | 10,673,700 | SH | | DFND | 1 | 10,673,700 | 0 | 0 |
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 17,951 | 2,054,794 | SH | | DFND | 1 | 2,054,794 | 0 | 0 |
WEREWOLF THERAPEUTICS INC | COM | 95075A107 | 4,321 | 958,125 | SH | | DFND | 1 | 958,125 | 0 | 0 |
WINDTREE THERAPEUTICS INC | COM | 97382D303 | 6 | 20,148 | SH | | DFND | 1 | 20,148 | 0 | 0 |
XERIS BIOPHARMA HOLDINGS INC | NOTE 5.000% 7/1 | 98422LAA5 | 17,384 | 18,000,000 | PRN | | DFND | 1 | 18,000,000 | 0 | 0 |